I agree with you and still hopeful the CLBP trial will be successful.
As for the CHF trial, I think a big pharma will soon put up his hand for partnership and takes a leading role to negotiate with FDA and bring Revascor to market for advanced CHF with or without another Phase 3 trial eventually.
However, I'm pessimistic with all causes ARDS application. Novartis may walk out before ink on contract has dried.
Today I sold half of my MSB shares the very 1st time after years of accumulation.
I've mixed feelings ....... I so hope MSB to succeed, but the stress to hold such large parcel is just too much for me and my family.
I'll continue to hold 1/2 of my original holdings , hopeful till we recive FDA approval in at least one application.
Good Luck to all true believers!
Silly Old Man
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-498
-
- There are more pages in this discussion • 578 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 98.0¢ | $4.720M | 4.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 171759 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 16000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |